Background: Limited evidence suggests that migraine might be a risk factor for
| INTRODUCTION
Migraine is a common chronic condition associated with increased risk of stroke and possibly other cardiovascular diseases involving the arteries or heart. [1] [2] [3] [4] At least 4 reports [4] [5] [6] [7] have suggested that migraine history also may carry an increased risk of venous thromboembolism (VTE)-that is, deep vein thrombosis (DVT) and/or pulmonary embolism (PE). A recent large, record-based, prospective
Danish study (median age: 35 years) showed that VTE incidence over 19 years of follow-up was 1.59 times more frequent in those with clinically recognized migraine than those with no evidence of migraine 4 ; the associations were similar for migraine with and without aura. A prospective clinical study in Taiwan (mean age = 42 years) reported that migraine with aura, but not migraine without aura or total migraine, was associated >2-fold increased risk of VTE over 4 years of follow-up compared with having no headache. 5 A cross-sectional population-based German study showed that 55-to 94-year-old participants with migraine had a 2-fold higher age-and sex-adjusted history of VTE than did nonmigraine patients. 6 Additionally, in a large, population-based, cross-sectional sample of pregnant women, VTE discharge codes during pregnancy were 3-fold more common in those with peripartum migraine vs no migraine. 7 Migraine may trigger ischemic stroke via cerebral vasoconstriction, arterial thrombi, or cortical spreading depression, [1] [2] [3] [4] but VTE has a different pathophysiology-more related to venous stasis and coagulation factor activation. Thus, how migraine might "cause" VTE is unclear. Migraine is not consistently associated with plasma hemostatic factors or genetic variants that predispose to VTE. 8, 9 High estrogen states can contribute to migraine and VTE, but in that case, hyperestrogenemia would be the cause of VTE, not migraine. Perhaps migraine could lead to immobility, predisposing to VTE. On the other hand, previous cross-sectional, clinical, or record-based studies showing an association of migraine with VTE may have suffered from misclassification, uncontrolled confounding, or a positive publication bias.
The large population-based prospective Atherosclerosis Risk in Communities (ARIC) study queried participants about migraine symptoms and identified and validated VTE events by medical record review. Using these data, we assessed (a) whether migraine history is a risk factor for future VTE and (b) whether migraine history is associated with hemostatic risk markers for VTE-namely, plasma factor VIII, factor XI, von Willebrand factor, activated partial thromboplastin time (aPTT), D-dimer, and a 5-single nucleotide polymorphism genetic risk score for VTE.
| MATERIALS AND METHODS

| Study design and sample
We reported elsewhere details of the overall ARIC study design, methods, and baseline participation, 10, 11 as well as the VTE incidence rates. 12 
| Statistical methods
visit 3), 38 who were of race groups other than black or white, 136 who were taking anticoagulants at visit 3, and 368 missing informa
| RESULTS
At baseline among participants free of VTE, the mean age was 60 years (SD: 6), and 11% were classified by the ARIC headache questionnaire as having a migraine history (n = 932 without aura and 396 with aura). Those having a migraine history were more likely to self-report a physician diagnosis of migraines, more often women than men, and more often whites than blacks ( risk of death (not shown), Figure 1 and Table 2 results were nearly identical.
The statistically nonsignificant patterns shown in Table 2 were similar for DVT and PE and for unprovoked and provoked VTE, when analyzed separately (Tables S1 and S2 ).
In the secondary analysis (Table 3) , VTE also was not significantly associated with a self-reported physician diagnosis of migraine headaches (Model 2, HR for yes vs no: 1.22, 95% CI: 0.96-1.55).
| DISCUSSION
This prospective population-based study of older adults showed no significant association between migraine history and incident VTE. This was true for migraine history both with aura and without aura. Furthermore, a self-reported physician diagnosis of migraine headaches was not associated with VTE. In addition, we found no apparent association of migraine history with important plasma hemostatic factors or with a 5-single nucleotide polymorphism genetic risk score for VTE. These lines of evidence suggest that migraine is not an important risk factor for VTE in older adults.
Our findings contrast with 4 previous reports associating a migraine diagnosis with VTE. [4] [5] [6] [7] These studies differed from ours in many ways-study design (2 cohort, 2 cross sectional), population and age sampled, exposure and outcome definitions, and control of confounding variables. Our study was population based, prospective, queried migraine symptoms in all (as opposed to only capturing individuals who sought medical care), was well controlled for confounding variables, and studied validated VTEs rather than relying solely on International Classification of Diseases codes. Yet our study had some drawbacks. First, ARIC defined migraine history by standard questions about headache duration and symptoms obtained 1 time and did not obtain physician confirmation of migraine diagnosis. Thus, migraine history is undoubtedly somewhat Fourth, ARIC follow-up for VTE occurrence was long. This is relevant because Adelborg et al 4 found that the association of migraine with VTE was stronger in the short term (0-1 year) than in the long term (up to 19 years) after diagnosis. Our study did not have year of migraine onset and, in any case, was not large enough to examine VTE incidence in the 2-year period following the migraine assessment. Finally, 3 of the 4 prior studies suggested the association between migraine and aura might be at least 2-fold, [5] [6] [7] and the other 1.6-fold. 4 Our study with 688 VTEs provided HRs that were relatively imprecise but should have had sufficient statistical power to rule out migraine doubling the risk of VTE. Power was certainly limited to determine whether migraine is a weak VTE risk factor (eg, HR: 1.2), and especially so when evaluating subsets of migraine with vs without aura. However, if migraine were such a weak risk factor for VTE, the association would be of little clinical or public health importance.
We did not find the VTE genetic risk score or several plasma hemostatic factors to be associated with migraine history, thus providing no additional mechanistic support for an association of migraine with VTE. Admittedly, we cannot rule out the possibility that a migraine episode may change hemostatic factors acutely and thereby trigger a VTE. All in all, the methodologic flaws and inconsistent findings of existing studies prevents firm conclusions about whether migraine affects hemostasis. 8 In summary, in contrast to 2 previous cohort studies of younger migraineurs, this study does not support the hypothesis that migraine history is an important risk factor for VTE in older adults.
However, imprecision of our HRs prevents firm conclusions about whether migraine might be a modest VTE risk factor.
